CCEL — Cryo-Cell International Cashflow Statement
0.000.00%
Last trade - 00:00
- $72.13m
- $79.71m
- $31.34m
- 76
- 23
- 89
- 66
2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | 2023 November 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2.29 | 3.62 | 2.08 | 2.77 | -9.52 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 2.87 | 2 | 1.59 | 1.78 | 17.8 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 2.28 | 3.76 | 4.86 | 4.25 | 5.99 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 6.32 | 8.47 | 7.93 | 8.57 | 8.92 |
Capital Expenditures | -0.662 | -0.1 | -1.84 | -12.2 | -6.84 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -0.028 | 0.457 | -5.11 | -3.11 | -1.31 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -0.691 | 0.357 | -6.95 | -15.3 | -8.14 |
Financing Cash Flow Items | -0.045 | -0.045 | 0 | -0.197 | -0.068 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -5.13 | -5 | -3.07 | 0.148 | -2.07 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.501 | 3.82 | -2.1 | -6.56 | -1.3 |